Stock Comparison

HLN vs TEVA

Haleon plc and Teva Pharma Industries Ltd ADR side by side — valuation, profitability, growth and risk.

HLN

Haleon plc

Healthcare

TEVA

Teva Pharma Industries Ltd ADR

Healthcare

Valuation

Market Cap

$43.55B

$41.60B

P/E (TTM)

20.2

59.5

Forward P/E

18.0

17.2

Price/Sales

3.9

2.4

Price/Book

2.0

5.4

EV/EBITDA

14.0

20.9

Dividend Yield

1.93%

—

Profitability

Net Margin

14.43%

9.02%

Operating Margin

21.32%

13.19%

Return on Equity

10.10%

9.69%

Return on Assets

5.08%

5.13%

Growth (YoY)

Revenue Growth

2.20%

-0.80%

Earnings Growth

-4.50%

72.20%

Price & Risk

Beta

0.2

0.9

52-Week High

$11.12

$36.74

52-Week Low

$8.61

$17.54

Analyst Target

$11.99

$41.20

Compare HLN and TEVA your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.